Evidence map›Paper›PMID 40588445›Full record

ArticleBJU international2025

Renal clearance of fluorescent agents can compromise image-guided surgery along the urinary tract.

Anne-Claire Berrens, Tessa Buckle, Matthias N van Oosterom, Leon J Slof, Belle M Melsert, Jakko A Nieuwenhuijzen, Esther M K Wit, Pim J van Leeuwen, Henk G van der Poel, Fijs W B van Leeuwen

Abstract read
In one paragraph

Article in BJU international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anne-Claire BerrensDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-3328-384X
Tessa BuckleDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Matthias N van OosteromDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Leon J SlofDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Belle M MelsertDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Jakko A NieuwenhuijzenDepartment of Urology, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands.
Esther M K WitDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Pim J van LeeuwenDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Henk G van der PoelDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-8772-1120
Fijs W B van LeeuwenDepartment of Urology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek
6 · The paper itself

Abstract

objectivesTo study the effect of renally cleared fluorescent agents on image-guided surgery along the urinary tract by using the renally cleared, non-tumour-specific, fluorescent dye fluorescein. SUBJECTS AND

methodsSixteen patients who underwent robot-assisted radical prostatectomy (RARP) with lymph node dissection received an intradermal injection of fluorescein. The slow-release of the fluorescein from the skin into the lymph- and bloodstream were used as a pharmacokinetic model for slow release from receptor-targeted agents. The presence of fluorescein in the urine and the surgical dissection planes around the prostate (representative of cancer margins) during RARP were evaluated. Suction, gauze and irrigation were used to try and reduce fluorescent background signals according to standard operating protocol.

resultsFluorescein was detected in the urine in the bedside catheter bag after a median of 1.3 h after agent administration and in the surgical field after opening the bladder neck as part of RARP (median of 2.4 h after injection). Suction and application of gauze helped to reduce contamination, but suction combined with irrigation with lukewarm NaCl 0.9% was shown to be most effective. Fluorescein accumulation was seen in the tissue surrounding the bladder neck in 80% of patients.

conclusionsRenally excreted fluorescent agents risk contamination of the surgical field and possible dissection margins along the urinary tract, a feature that, without proper counter measures, could compromise the accuracy of intra-operative imaging by creating false-positive findings. A clear example of this was the observed bladder neck staining with fluorescein.

Indexed as

FluoresceinFluorescent DyesProstatectomyProstatic NeoplasmsSurgery, Computer-AssistedAgedHumansLymph Node ExcisionMaleMiddle AgedRobotic Surgical ProceduresFluoresceinFluorescent Dyesfluoresceinfluorescence guided surgeryimage‐guided surgeryprostate cancerPSMAPSMA‐targeted surgeryradioguided surgerysurgical margin assessment

Identifiers

PMID40588445
PMCPMC12343974

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.